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Blood lymphocyte subsets after the first fraction in patients given
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Radiosensitivity of human lymphocytes was extensively
studied in vitro (Kwan & Norman, 1977; Manori et al., 1984;
Prosser, 1976; Szczylik & Wiktor-Jedrzejczak, 1981; Wasser-
man et al., 1982a, b) and in vivo (Haas et al., 1984; Hoppe et
al., 1977; Job et al., 1984; Kotzin et al., 1983; Petrini et al.,
1977; Posner et al., 1983; Schulof et al., 1985; Idestrom et al.,
1979). Results are confficting but suggest that B lymphocytes
and helper T cells are more radiosensitive than T lympho-
cytes and cytotoxic/suppressor cells respectively. However,
data from in vitro and in vivo experiments are not really
convincing. On the one hand in vitro conditions may not
accurately reflect in vivo conditions. On the other hand, in
the in vivo studies radiation treatment was only given to a
part of the hemopoietic and/or lymphoid system. Therefore a
redistribution and/or repopulation of lymphocytes from non
irradiated areas might have occurred and prevented an
accurate evaluation of the radiosensitivity of the peripheral
blood lymphocyte subsets. Furthermore it has recently been
suggested that a possible radioresistant lymphocyte subset
might be responsible for the rejection of T cell depleted bone
marrow grafts after conditioning treatment with total body
irradiation and chemotherapy (Dennert et al., 1985; Hall &
Dorsch, 1984). We therefore decided to undertake our own in
vivo study to determine the radiosensitivity of different lym-
phocyte subsets and try to pinpoint a particular radioresis-
tant subset which could be incriminated in graft rejection. In
our institution, hyperfractionated total body irradiation pro-
vided us with a unique model for the study of lymphocyte
radiosensitivity in vivo. This model is unique in that irradia-
tion was given to the whole lymphoid and bone marrow
system thus preventing possible redistribution and/or repop-
ulation from non irradiated areas.
Patients included in the study were leukaemia patients in
complete remission and without any therapy for at least a
month. Hyperfractionated total body irradiation (HTBI) was
delivered in 11 fractions over 4 days, three fractions of
120-135 cGy a day. The first fraction was given on Monday
at 6 pm, and the second fraction on Tuesday morning at
7.30 am. The study on lymphocytes took place between those
two fractions. Lymphocyte blood counts were determined
before radiation treatment in the morning (6 am), and just
before the first radiation treatment (6 pm). After the first
fraction they were determined 4 and 12 h later. Blood sam-
ples for lymphocyte subset analysis were obtained 12 h before
and 12 h after the first fraction of TBI (120-135 cGy).
The staining of the lymphocyte subsets was done as fol-
lows. First and second stage reagents were diluted in PBS
0.2% sodium azide and were used at concentrations shown
to be at a saturation point. Briefly 0.5 x 106 cells were re-
suspended with 50 il of the non fluoresceinated first stage
antibodies CD2, CD4, CD8, CD,, HLA DR and NKH1
kindly provided by Drs E. Reinberg, S.F. Schlossman and T.
Hercend. After a 30 min incubation on ice cells were washed
with ml of PBS azide and 0.5 ml of heat inactivated foetal
calf serum. Then the cells were incubated with the second-
stage fluoresceinated antibody (Melay Laboratoire Spring-
field, VA) for 30 min on ice. After two washes with PBS
azide, cells were resuspended and analysed using cytofluoro-
metry (Ortho System 50H, Westwood, MA). The percentage
of positively staining cells was determined by integrating the
logarithmic fluorescence curve from the left shoulder inflec-
tion point. In most cases background staining was approx-
imately 2%.
In the present investigation because the fraction size was
relatively small blood lymphocyte numbers were high enough
to allow an adequate study of the decline in the different
lymphocyte subsets. The size of the fraction also seemed to
be appropriate for the studies of lymphocyte radiosensitivity,
because cell or tissue radiosensitivity is better defined by its
surviving fraction at 2 Gy (Fertil & Malaise, 1981; Deacon et
al., 1984). From March 1988 to July 1989, 20 patients were
entered into the study. The mean age was 18.8 ± 8.5. Eleven
patients were diagnosed as having ALL, five patients had
ANLL, one patient had CML, and three had lymphoblastic
lymphoma. All patients were in complete remission and off
therapy for at least 1 month.
The decrease in peripheral blood lymphocytes during a
hyperfractionated TBI has already been described by Shank
et al. (1983). In our study we focused on early cell kinetics
after the first fraction of a hyperfractionated TBI. Total
lymphocyte counts decreased to approximately 65% (64 +
17%) of the pretreatment counts (morning values preceding
the first radiation treatment). Interestingly a sharp drop
occurred in the first 4 h (75% of the total decrease) with a
further but slow decline in the following 8 h (Figure 1). This
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Figure 1 Lymphocyte percentages before and after the first frac-
tion of TBI (120- 135 cGy).
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finding suggested that at least 4 to 12 h are required after
radiation treatment to adequately assess the decline in lym-
phocytes. An overestimation in lymphocyte survival might
occur if such an interval is not respected. It is noteworthy to
underline that the substantial drop in the first 4 h in vivo does
not occur in vitro which is only observed after 2 to 3 days
(Prosser, 1976; Szczylik & Wiktor-Jedrzejczak, 1981; Wasser-
man et al., 1982b; Dutreix et al., 1987). These different
kinetics between in vivo and in vitro experiments seem to
suggest a rapid removal of doomed lymphocytes in vivo by a
yet unknown mechanism.
In our study all lymphocyte subsets appeared to be equally
sensitive to the in vivo radiation (Table I). These findings
contradict many previous in vivo studies (Job et al., 1984;
Kotzin et al., 1983; Petrini et al., 1977; Posner et al., 1983;
Schulof et al., 1985; Toivanen et al., 1984; Idestrom et al.,
1979). This discrepancy could be explained by two facts.
Firstly, in earlier studies irradiation was given to a part of
the hemopoietic and lymphoid system; therefore lymphocyte
redistribution from non irradiated areas might have occurred,
especially from bone marrow where the majority of lympho-
cytes are CD8 with lesser numbers of CD4 (Janossy et al.,
1980, 1987). This phenomenon might have lead to a larger
increase in CD8 cells suggesting CD8 radioresistance.
Secondly, in earlier studies (Wasserman et al., 1982a; Hoppe
et al., 1977; Job et al., 1984; Schulof et al., 1985; Onsrud et
al., 1982) lymphocyte subsets were analysed 2 to 16 weeks
after the beginning of the radiation treatment. This period of
time might have allowed more rapid CD8 repopulation as
already shown in multiple studies (Haas et al., 1984; Kotzin
et al., 1983; Posner et al., 1983; our unpublished data) and
therefore lead to a false impression of CD8 radioresistance.
Table I Lymphocyte subsets determined in 20 patients 12 h after a
total body irradiation dose of 120-135 cGya
(mean±standard deviation)
Helper Suppressor/cytotoxic Natural
B cells T cells T cells T cells killer cells
(IA) (CD2) (CD4) (CD8) (NKHI)
49±21 51 ±21 59±22 60±23 54±26
aPercentage ofcontrol values time (determined in the morning prior
to the first fraction of TBI).
An additional factor could explain the different results
between our study and other in vivo studies. In our study the
TBI dose yielded a decrease in lymphocyte numbers which
might have been too small to detect any difference in radio-
sensitivity among the lymphocyte subsets. The study of the
lymphocyte subsets during and at the end of the total body
irradiation might have provided additional information on
their radiosensitivity, but was not feasible for practical and
ethical reasons.
In conclusion, this study showed that the disappearance of
peripheral blood lymphocytes occurred 4 to 12 h after the
first fraction ofTBI and that the different lymphocyte subsets
(T and B lymphocytes, helper and cytotoxic/suppressor T
lymphocytes, natural killer cells) exhibited equal radiosen-
sitivity.
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